{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T02:18:35Z","timestamp":1773627515961,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpba.2015.05.025","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T15:41:18Z","timestamp":1433518878000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Analytical and physicochemical characterisation of the senile cataract drug dipeptide \u03b2-alanyl-L-histidine (carnosine)"],"prefix":"10.1016","volume":"114","author":[{"given":"Hamdy","family":"Abdelkader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Swinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara K.","family":"Pierscionek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raid G","family":"Alany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.05.025_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0010-406X(70)90049-6","article-title":"Carnosine and related substances in animal tissues","volume":"34","author":"Crush","year":"1970","journal-title":"Comp. Biochem. Physiol."},{"key":"10.1016\/j.jpba.2015.05.025_bib0010","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1021\/jf047934h","article-title":"Quantitation of carnosine in humans plasma after dietary consumption of beef","volume":"53","author":"Park","year":"2005","journal-title":"J. Agric. Food. Chem."},{"key":"10.1016\/j.jpba.2015.05.025_bib0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1196\/annals.1354.052","article-title":"Would carnosine or a carnivorous diet help suppress aging and associated pathologies","volume":"1067","author":"Hipkiss","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jpba.2015.05.025_bib0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1442-9071.2007.01559.x","article-title":"Medical treatment of cataract","volume":"35","author":"Toh","year":"2007","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.jpba.2015.05.025_bib0025","first-page":"31","article-title":"N-acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population","volume":"4","author":"Babizhayev","year":"2009","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.jpba.2015.05.025_bib0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","article-title":"Advanced glycation end products in alzheimer\u2019s disease and other neurodegenerative diseases","volume":"153","author":"Sasaki","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"September 15 (13)","key":"10.1016\/j.jpba.2015.05.025_bib0035","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0047-6374(01)00272-X","article-title":"Carnosine, the anti-ageing, anti-oxidant dipetide, may react with protein carbonyl groups","volume":"122","author":"Hipkiss","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.jpba.2015.05.025_bib0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jphp.12355","article-title":"Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens","volume":"67","author":"Abdelkader","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpba.2015.05.025_bib0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0003-2697(80)90589-8","article-title":"Spectrophotometric determination of carnosine, anserine, and taurine in skeletal muscle","volume":"108","author":"Parker","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2015.05.025_bib0050","first-page":"74","article-title":"Detection and estimation of carnosine, anserine and novel imidazoles in cardiac and skeletal muscles in several species by high performance liquid chromatography","volume":"398","author":"Chrinchton","year":"1988","journal-title":"J. Physiol."},{"key":"10.1016\/j.jpba.2015.05.025_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-4165(88)90015-3","article-title":"Detection, characterisation, and quantification of carnosine and other histidyl derivatives in cardiac and skeletal muscle","volume":"967","author":"O'Dowd","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpba.2015.05.025_bib0060","unstructured":"ICH(Q2), Validation of analytical procedures: text nd methodology Q2 (R1), (November 2005)."},{"issue":"February","key":"10.1016\/j.jpba.2015.05.025_bib0065","first-page":"48","article-title":"Vailable guidance and best practices for conducting forced degradation studies","author":"Reynolds","year":"2002","journal-title":"Pharm. Technol."},{"issue":"February","key":"10.1016\/j.jpba.2015.05.025_bib0070","first-page":"60","article-title":"A stress testing benchmarking study","author":"Alsante","year":"2003","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.jpba.2015.05.025_bib0075","first-page":"2385","article-title":"Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation","volume":"8","author":"Freag","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jpba.2015.05.025_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1773-2247(11)50017-6","article-title":"Preformulation characteristics of the opioid growth factor antagonist-naltrexone hydrochloride: stability and lipophilicity studies","volume":"21","author":"Abdelkader","year":"2011","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jpba.2015.05.025_bib0085","series-title":"Physichochemical Principles of Pharmacy","first-page":"152","article-title":"The solubility of drugs","author":"Florence","year":"1998"},{"key":"10.1016\/j.jpba.2015.05.025_bib0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jps.20282","article-title":"Physichochemical characterisation of ricobendazole: I. solubility, lipophilicity and ionization charactersitics","volume":"94","author":"Wu","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.05.025_bib0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jps.2600810324","article-title":"Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies","volume":"81","author":"Shah","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.05.025_bib0100","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jps.2600670614","article-title":"Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients","volume":"67","author":"Schoenwald","year":"1978","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.05.025_bib0105","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jps.2600721108","article-title":"Corneal penetration behavior of beta blocking agents I: physichochemical factors","volume":"72","author":"Schoenwald","year":"1983","journal-title":"J. Pharm. Sci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515300066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515300066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T04:53:33Z","timestamp":1537592013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515300066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":21,"alternative-id":["S0731708515300066"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.05.025","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical and physicochemical characterisation of the senile cataract drug dipeptide \u03b2-alanyl-L-histidine (carnosine)","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}